ISA Pharmaceuticals
Blood & Organ Banks · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 De Limes, Oegstgeest, South Holland, N...Phone Number
+31 858229292Website
www.isa-pharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
2
3
1
About ISA Pharmaceuticals
Founded in 2004, based out of the Netherlands, ISA Pharmaceuticals B.V. is an immunotherapy company developing treatments for various cancers and infectious diseases. ISA Pharmaceuticals has best-in-class technology to stimulate and activate the human immune system, specifically T cells, to fight diseased or infected cells. Its lead asset ISA101b is in late-stage clinical trials for human papillomavirus type 16 (HPV16) induced cancers in a collaboration with US pharmaceutical company Regeneron.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ISA Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ISA Pharmaceuticals launches new products
Check if ISA Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on ISA Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ISA Pharmaceuticals
Funding: Get notified immidiatlly once ISA Pharmaceuticals has new funding data
ISA Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ISA Pharmaceuticals had a recent Job posting/layoffs
Check out if ISA Pharmaceuticals is spiking on competitors!
Recommended Actions
Find VP level buyers at ISA Pharmaceuticals
Find 2 more new buyers
Company Profile Activity
Activity Insights
ISA Pharmaceuticals is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
ISA Pharmaceuticals is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about ISA Pharmaceuticals.
ISA Pharmaceuticals financials insights
Gather financial insights about ISA Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Unspecified
$30.7M
ISA Pharmaceuticals Tech Stack
A closer look at the technologies used by ISA Pharmaceuticals
See more technologies
ISA Pharmaceuticals News & Media
First Patient with Chronic Hepatitis B Dosed with ISA104 in First-in-Human Phase 1 Study
Study by Erasmus MC marks first clinical development milestone for ISA104 immunotherapeutic treatment of chronic hepatitis B infection OEGSTGEEST, Netherlands, Aug. 31, 2023 /PRNewswire/ -- ISA Pharmaceuticals B.V., a clinical-stage biotech company developing immunotherapies to treat...The combination of ISA101b and Libtayo® shows promising results in patients whose head and neck cancer progressed on anti-PD1 therapy
Early data presented at ASCO annual meeting 2023 shows encouraging responses to treatment in a very difficult to treat patient population Dr. Anthony Kong (Guy's and St Thomas' Hospitals, London), Principal Investigator, presented data from ProcemISA, an ongoing clinical trial in anti-PD1...ISA Pharmaceuticals to Present First Clinical Trial Data from the Phase II Study of ISA101b and Libtayo® (cemiplimab) Combination in Head and Neck Cancer at the ASCO Annual Meeting 2023
- Dr. Anthony Kong (Guy's and St Thomas' Hospitals, London), Principal Investigator, will present data from ProcemISA, an ongoing clinical trial in anti-PD1 resistant advanced head and neck cancer - This study is part of an extensive clinical development programme in HPV16 induced cancers...ISA Pharmaceuticals to Present Pre-clinical Data on its Protective SLP Therapy Against SARS-CoV-2 at the CIMT Annual Meeting
OEGSTGEEST, The Netherlands, April 27, 2023 /PRNewswire/ -- ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that it will be presenting data evaluating the response to its T cell...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ISA Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2004, based out of the Netherlands, ISA Pharmaceuticals B.V. is an immunotherapy company developing treatments for various cancers and infectious diseases. ISA Pharmaceuticals has best-in-class technology to stimulate and activate the human immune system, specifically T cells, to fight diseased or infected cells. Its lead asset ISA101b i... Read More
